Skip to content

Clinical trials

Phase 3 Inflammatory Bowel Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 3 Country / region: Australia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20102
20114
20121
20151
20182
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC5
Eli Lilly and Company2
GlaxoSmithKline2
InDex Pharmaceuticals1
Janssen Biotech, Inc.1
Merck Sharp & Dohme LLC1
Murdoch Childrens Research Institute1
Pfizer1
The University of New South Wales1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases15
Crohn Disease7
Colitis, Ulcerative6
Colitis3
Arthritis, Juvenile2
Autoimmune Diseases1
Gastrointestinal Diseases1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1
Renal Insufficiency, Chronic1
Uterine Cervical Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.